Daniel Handley

Daniel Handley

Director/Board Member at PRECISION THERAPEUTICS INC

Net worth: 76 949 $ as of 30/05/2026

66 year
Consumer Services
Commercial Services
Health Technology

Profile

Daniel E.
Handley
is currently Director at Translational Genomics Research Institute since 2019, Independent Director at Axe Compute, Inc. since 2020, and Professor at Southern California University of Health Sciences since 2019.
Former positions include Laboratory Manager at David Geffen School of Medicine from 1991 to 1994, Chief Scientific Officer at Life-SEQ LLC, and Chief Scientific Officer at Advanced Healthcare Technology Solutions, Inc. from 2010 to 2013.
Education includes graduate studies at Carnegie Mellon University, a doctorate from the University of Pittsburgh, and undergraduate studies at The Johns Hopkins University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
19/04/2026 11,040 ( 0.33% ) 76 949 $ 30/05/2026

Daniel Handley active positions

CompaniesPositionStart
PRECISION THERAPEUTICS INC Director/Board Member 18/02/2020
Corporate Officer/Principal 31/03/2019
Director/Board Member 31/03/2019

Former positions of Daniel Handley

CompaniesPositionEnd
Advanced Healthcare Technology Solutions, Inc.
Chief Tech/Sci/R&D Officer 31/12/2012
Corporate Officer/Principal 31/12/1993
Chief Tech/Sci/R&D Officer -
See the detail of Daniel Handley's experience

Training of Daniel Handley

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

11

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Health Technology

Consumer Services

Consumer Services

Commercial Services

Advanced Healthcare Technology Solutions, Inc.

  1. Stock Market
  2. Insiders
  3. Daniel Handley
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!